Using real world decisions to develop a modified central IRB model
Using real world decisions to develop a modified central IRB model
批准号:
8927057
负责人:
TODD W RICE
金额:
$28.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-15 至 2016-04-30
关键词:
AddressAgreementCognitiveDataData AnalysesEffectivenessEnsureEthicsEvaluationFoundationsFundingFutureHealthHumanInformaticsInstitutionInstitutional Review BoardsInvestigationLeadLeadershipLearningLegalLettersMeasuresMedicalMethodsMissionModelingModificationMovementMulticenter StudiesNatural experimentOffice for Human Research ProtectionsOnline SystemsOutcomeOutcome MeasurePhysician ExecutivesPoliciesPredispositionProceduresProcessProcess MeasureProtocols documentationResearchResearch InfrastructureResearch PersonnelRiceSecureSolutionsSystemTimeTrustWorkbasecontextual factorsdesignempoweredevidence baseexperiencehuman subjecthuman subject protectionimprovedoperationprogramssatisfactionstemstudy characteristics
中文摘要
描述(由申请人提供):IRB对多中心研究的审查已知效率低下,产生可变结局,可能无法充分保护人类受试者。一种建议的解决方案是利用中央IRB(CIRB)审查;然而,现有的CIRB模型具有显著的可扩展性问题,并且由于利用率低而缺乏有效性的经验证据。了解IRB如何以及为什么在研究背景下决定什么IRB审查模型是最好的,对于设计一个适应这些决定的模型至关重要。鉴于多中心研究对CIRB或替代IRB审查模式的适用性可能差异很大,单一IRB审查模式可能不足以用于多个不同机构的研究。支持IRB共享的现有基础设施可用于适应多种IRB审查模式(包括共享审查、中央审查和本地审查),并为随后在操作过程中捕获数据提供真实的世界平台。据推测,授权机构有机会选择的模式,上下文最好的工作的基础上的机构和研究的特点,将鼓励更多的利用,反过来可以提高道德质量和多站点IB审查的有效性。将使用定性和定量测量和分析,分析在有多个审查选项(“IRB选择”)的情况下,为给定研究选择IRB审查模式的选择、利用、过程和依据。具体目标:1)使用适应的信息系统和协调程序来跟踪真实的世界决策,并获取选择IRB依赖模型时使用的基本原理,包括在机构、法律的、HRPP/IRB、研究者和研究层面使用替代IRB审查模型的促进因素和障碍; 2)比较关键过程和结局指标的替代审查模型:a)道德质量,B)审评过程的效率,以及c)多个利益攸关方对审评过程的满意度(IRB、申办者/资助者、研究者/研究团队);和3)制定和分享政策和程序,以减轻道德或后勤问题,并最大限度地提高与动态使用替代审查模型(包括CIRB)相关的效率模型
英文摘要
DESCRIPTION (provided by applicant): The IRB review of multicenter studies has known inefficiencies, produces variable outcomes, and may not sufficiently protect human subjects. One proposed solution has been the utilization of central IRB (CIRB) review; however, existing CIRB models have significant scalability issues and lack empirical evidence of effectiveness due to low utilization. Understanding how and why IRBs decide what IRB review model is best within the study context is essential to designing a model that accommodates these decisions. Given that the suitability of a multicenter study for CIRB or an alternative IRB review model may vary widely, a single IRB review model may not be sufficient for a study with multiple, diverse institutions. The existing infrastructure supporting IRBshare can be leveraged to accommodate multiple IRB review models - including shared review, central review, and local review - and provide a real world platform for subsequently capturing data in the course of operations. It is hypothesized that empowering institutions with the opportunity to choose the model that contextually works best-based on the institutional and study characteristics-will encourage greater utilization that can in turn improve the ethical quality and efficaciousness of multisite IB review. The choices, utilization, process, and rationale for selecting an IRB review model for a given study when multiple review options are available ("IRBchoice") will be analyzed using qualitative and quantitative measures and analyses. SPECIFIC AIMS: 1) To use an adapted informatics system and coordinated program to track real world decisions and capture the rationale used when selecting an IRB reliance model, including the facilitators and barriers to utilizing alternative IRB review models at the institutional, legal, HRPP/IRB, investigator, and study levels; 2) To compare the alternative review models on key process and outcome measures: a) ethical quality, b) efficiency of the review process, and c) satisfaction with the review process by multiple stakeholders (IRB, sponsor/funder, investigator/study team); and 3) To develop and share policies and procedures to mitigate ethical or logistical issues and maximize efficiency related to the dynamic use of alternative review models including the CIRB model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using real world decisions to develop a modified central IRB model
-
批准号:8840421
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2014
-
负责人:TODD W RICE
-
依托单位:
Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network
-
批准号:9063082
-
项目类别:
-
资助金额:$37.7万
-
财政年份:2014
-
负责人:TODD W RICE
-
依托单位:
Citrulline to Prevent or Mitigate Acute Lung Injury in Severe Sepsis
-
批准号:8610942
-
项目类别:
-
资助金额:$30.58万
-
财政年份:2012
-
负责人:TODD W RICE
-
依托单位:
Citrulline to Prevent or Mitigate Acute Lung Injury in Severe Sepsis
-
批准号:8424973
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2012
-
负责人:TODD W RICE
-
依托单位:
Citrulline to Prevent or Mitigate Acute Lung Injury in Severe Sepsis
-
批准号:8240853
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2012
-
负责人:TODD W RICE
-
依托单位:
Attenuating Inflammation via Protein-Calorie Restriction
-
批准号:7913067
-
项目类别:
-
资助金额:$15.19万
-
财政年份:2006
-
负责人:TODD W RICE
-
依托单位:
Attenuating Inflammation via Protein-Calorie Restriction
-
批准号:7475149
-
项目类别:
-
资助金额:$15.19万
-
财政年份:2006
-
负责人:TODD W RICE
-
依托单位:
Attenuating Inflammation via Protein-Calorie Restriction
-
批准号:7294344
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2006
-
负责人:TODD W RICE
-
依托单位:
Attenuating Inflammation via Protein-Calorie Restriction
-
批准号:7133071
-
项目类别:
-
资助金额:$15.19万
-
财政年份:2006
-
负责人:TODD W RICE
-
依托单位:
Attenuating Inflammation via Protein-Calorie Restriction
-
批准号:7666915
-
项目类别:
-
资助金额:$15.19万
-
财政年份:2006
-
负责人:TODD W RICE
-
依托单位:
海外基金